Acadia Healthcare Company (ACHC) EBITDA Margin (2010 - 2026)

Acadia Healthcare Company has disclosed EBITDA Margin across 17 years of filings, most recently posting 14.49% for Q1 2026.

• In Q1 2026, EBITDA Margin fell 1256.0% year-over-year to 14.49%; the TTM figure through Mar 2026 stood at 41.38% (down 4044.0% YoY), while the FY2025 annual figure was 1.05%, down 265.0% from the prior year.
• EBITDA Margin advanced to 14.49% in Q1 2026, from 146.1% in the prior quarter.
• Over the last five years, EBITDA Margin for ACHC reached as high as 9.87% in Q2 2024 and fell as low as 146.1% in Q4 2025.
• The 5-year median for EBITDA Margin is 1.66% (2024), against an average of 15.31%.
• Annual changes were most pronounced in 2024 — EBITDA Margin surged 4026 bps — and 2025, when it sank 13578 bps.
• A 5-year view of EBITDA Margin shows it stood at 27.68% in 2022, then retreated by 12 bps to 30.91% in 2023, then soared by 67 bps to 10.32% in 2024, then slumped by 1316 bps to 146.1% in 2025, then surged by 90 bps to 14.49% in 2026.
• According to Business Quant data, EBITDA Margin over the past three periods registered 14.49%, 146.1%, and 1.12% for Q1 2026, Q4 2025, and Q3 2025 respectively.